The PAKs come of age: Celebrating 18 years of discovery

por Field, Jeffrey, Manser, Ed
Publicado 2012

PAK signaling in cancer

por Ye, Diana Zi, Field, Jeffrey
Publicado 2012

p21-Activated Kinase 1 (Pak1) Phosphorylates BAD Directly at Serine 111 In Vitro and Indirectly through Raf-1 at Serine 112

por Ye, Diana Z., Jin, Shenghao, Zhuo, Ya, Field, Jeffrey
Publicado 2011

Publicly available data reveals association between asthma hospitalizations and unconventional natural gas development in Pennsylvania

por Bushong, Anna, McKeon, Thomas, Regina Boland, Mary, Field, Jeffrey
Publicado 2022

G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment

por Lee, Yool, Lahens, Nicholas F., Zhang, Shirley, Bedont, Joseph, Field, Jeffrey M., Sehgal, Amita
Publicado 2019

Fourier computed tomographic imaging of two dimensional fluorescent objects

por Stockton, Patrick A., Wernsing, Keith A., Field, Jeffrey J., Squier, Jeff, Bartels, Randy A.
Publicado 2019

Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3β

por Xie, Shuanshuan, Liu, Yang, Li, Xuan, Tan, Min, Wang, Changhui, Field, Jeffrey, Zhou, Guo-Lei
Publicado 2018

Remote focusing for programmable multi-layer differential multiphoton microscopy

por Hoover, Erich E., Young, Michael D., Chandler, Eric V., Luo, Anding, Field, Jeffrey J., Sheetz, Kraig E., Sylvester, Anne W., Squier, Jeff A.
Publicado 2010

Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle

por Lee, Yool, Fong, Shi Yi, Shon, Joy, Zhang, Shirley L., Brooks, Rebekah, Lahens, Nicholas F., Chen, Dechun, Dang, Chi Van, Field, Jeffrey M., Sehgal, Amita
Publicado 2021

c-Abl phosphorylates Dok1 to promote filopodia during cell spreading

por Woodring, Pamela J., Meisenhelder, Jill, Johnson, Sam A., Zhou, Guo-Lei, Field, Jeffrey, Shah, Kavita, Bladt, Friedhelm, Pawson, Tony, Niki, Masaru, Pandolfi, Pier Paolo, Wang, Jean Y.J., Hunter, Tony
Publicado 2004

CAP2 in cardiac conduction, sudden cardiac death and eye development

por Field, Jeffrey, Ye, Diana Z., Shinde, Manasi, Liu, Fang, Schillinger, Kurt J., Lu, MinMin, Wang, Tao, Skettini, Michelle, Xiong, Yao, Brice, Angela K., Chung, Daniel C., Patel, Vickas V.
Publicado 2015

Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye development

por Field, Jeffrey, Ye, Diana Z., Shinde, Manasi, Liu, Fang, Schillinger, Kurt J., Lu, MinMin, Wang, Tao, Skettini, Michelle, Xiong, Yao, Brice, Angela K., Chung, Daniel C., Patel, Vickas V.
Publicado 2016

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

por Wang, Beike, Zhang, Wei, Zhang, Gao, Kwong, Lawrence, Lu, Hezhe, Tan, Jiufeng, Sadek, Norah, Xiao, Min, Zhang, Jie, Labrie, Marilyne, Randell, Sergio, Beroard, Aurelie, Sugarman, Eric, Rebecca, Vito W., Wei, Zhi, Lu, Yiling, Mills, Gordon B., Field, Jeffrey, Villanueva, Jessie, Xu, Xiaowei, Herlyn, Meenhard, Guo, Wei
Publicado 2021

Identification and Development of Therapeutics for COVID-19

por Rando, Halie M., Wellhausen, Nils, Ghosh, Soumita, Lee, Alexandra J., Dattoli, Anna Ada, Hu, Fengling, Byrd, James Brian, Rafizadeh, Diane N., Lordan, Ronan, Qi, Yanjun, Sun, Yuchen, Brueffer, Christian, Field, Jeffrey M., Guebila, Marouen Ben, Jadavji, Nafisa M., Skelly, Ashwin N., Ramsundar, Bharath, Wang, Jinhui, Goel, Rishi Raj, Park, YoSon, Boca, Simina M., Gitter, Anthony, Greene, Casey S.
Publicado 2021

Identification and Development of Therapeutics for COVID-19

por Rando, Halie M., Wellhausen, Nils, Ghosh, Soumita, Lee, Alexandra J., Dattoli, Anna Ada, Hu, Fengling, Byrd, James Brian, Rafizadeh, Diane N., Lordan, Ronan, Qi, Yanjun, Sun, Yuchen, Brueffer, Christian, Field, Jeffrey M., Ben Guebila, Marouen, Jadavji, Nafisa M., Skelly, Ashwin N., Ramsundar, Bharath, Wang, Jinhui, Goel, Rishi Raj, Park, YoSon, Boca, Simina M., Gitter, Anthony, Greene, Casey S.
Publicado 2021

PAK Signaling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas

por Lu, Hezhe, Liu, Shujing, Zhang, Gao, Wu, Bin, Zhu, Yueyao, Frederick, Dennie T., Hu, Yi, Zhong, Wenqun, Randell, Sergio, Sadek, Norah, Zhang, Wei, Chen, Gang, Cheng, Chaoran, Zeng, Jingwen, Wu, Lawrence W., Zhang, Jie, Liu, Xiaoming, Xu, Wei, Krepler, Clemens, Sproesser, Katrin, Xiao, Min, Miao, Benchun, Liu, Jianglan, Song, Claire D., Liu, Jephrey Y., Karakousis, Giorgos C., Schuchter, Lynn M., Lu, Yiling, Mills, Gordon, Cong, Yusheng, Chernoff, Jonathan, Guo, Jun, Boland, Genevieve M., Sullivan, Ryan J., Wei, Zhi, Field, Jeffrey, Amaravadi, Ravi K., Flaherty, Keith T., Herlyn, Meenhard, Xu, Xiaowei, Guo, Wei
Publicado 2017